GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shaanxi Panlong Pharmaceutical Group Ltd (SZSE:002864) » Definitions » Market Cap

Shaanxi Panlong Pharmaceutical Group (SZSE:002864) Market Cap : ¥3,082.1 Mil (As of May. 29, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shaanxi Panlong Pharmaceutical Group Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Shaanxi Panlong Pharmaceutical Group's share price for the quarter that ended in Mar. 2024 was ¥29.05. Shaanxi Panlong Pharmaceutical Group's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 106.3 Mil. Therefore, Shaanxi Panlong Pharmaceutical Group's market cap for the quarter that ended in Mar. 2024 was ¥3,087.5 Mil.

Shaanxi Panlong Pharmaceutical Group's quarterly market cap declined from Sep. 2023 (¥4,252.3 Mil) to Dec. 2023 (¥4,090.8 Mil) and declined from Dec. 2023 (¥4,090.8 Mil) to Mar. 2024 (¥3,087.5 Mil).

Shaanxi Panlong Pharmaceutical Group's annual market cap increased from Dec. 2021 (¥2,715.4 Mil) to Dec. 2022 (¥3,363.6 Mil) and increased from Dec. 2022 (¥3,363.6 Mil) to Dec. 2023 (¥4,090.8 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shaanxi Panlong Pharmaceutical Group's Enterprise Value for Today is ¥2,067.1 Mil.


Shaanxi Panlong Pharmaceutical Group Market Cap Historical Data

The historical data trend for Shaanxi Panlong Pharmaceutical Group's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shaanxi Panlong Pharmaceutical Group Market Cap Chart

Shaanxi Panlong Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,381.69 2,177.15 2,715.37 3,363.62 4,090.76

Shaanxi Panlong Pharmaceutical Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,747.24 4,087.46 4,252.30 4,090.76 3,087.46

Competitive Comparison of Shaanxi Panlong Pharmaceutical Group's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Shaanxi Panlong Pharmaceutical Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shaanxi Panlong Pharmaceutical Group's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shaanxi Panlong Pharmaceutical Group's Market Cap distribution charts can be found below:

* The bar in red indicates where Shaanxi Panlong Pharmaceutical Group's Market Cap falls into.



Shaanxi Panlong Pharmaceutical Group Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Shaanxi Panlong Pharmaceutical Group's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥38.49*106.281
=¥4,090.8

Shaanxi Panlong Pharmaceutical Group's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥29.05*106.281
=¥3,087.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shaanxi Panlong Pharmaceutical Group  (SZSE:002864) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Shaanxi Panlong Pharmaceutical Group Market Cap Related Terms

Thank you for viewing the detailed overview of Shaanxi Panlong Pharmaceutical Group's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Shaanxi Panlong Pharmaceutical Group (SZSE:002864) Business Description

Traded in Other Exchanges
N/A
Address
2801 Baliu 2nd Road, Modern Textile Ind Park Baqiao, Xian, CHN, 710025
Shaanxi Panlong Pharmaceutical Group Ltd operates as a pharmaceuticals company. It manufactures and markets drugs for the treatment of traumatology, cardiovascular and cerebrovascular, respiratory, pediatrics, and hepatobiliary.
Executives
Zhang De Zhu Directors, executives
Liu Zhao Supervisors
Jian Bao Liang Supervisors
Zhang Zhi Hong Directors, executives
Zhang Shui Ping Director
Wu Jie Directors, Directors, and Executives
Zhu Feng Ming Executives
Zhu Wen Feng Director
Xie Xiao Feng Director
Xie Xiao Lin Directors, executives

Shaanxi Panlong Pharmaceutical Group (SZSE:002864) Headlines

No Headlines